Product
LV20.19 CAR T cells
1 clinical trial
6 indications
Indication
Non-Hodgkin LymphomaIndication
Diffuse Large B-Cell LymphomaIndication
Follicular LymphomaIndication
Marginal Zone LymphomaIndication
mantle cell lymphomaIndication
Burkitt lymphomaClinical trial
Phase I Study of LV20.19 CAR T-cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell MalignanciesStatus: Not yet recruiting, Estimated PCD: 2026-07-01